Insider Transactions in Q2 2021 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
976
-1.26%
|
$34,160
$35.81 P/Share
|
|
Jun 28
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
293
-1.85%
|
$10,255
$35.81 P/Share
|
|
Jun 28
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
293
-1.13%
|
$10,255
$35.81 P/Share
|
|
Jun 16
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
42,242
-35.35%
|
$1,393,986
$33.75 P/Share
|
|
Jun 16
2021
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
42,242
+26.12%
|
$168,968
$4.12 P/Share
|
|
Jun 07
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-58.64%
|
$787,500
$35.0 P/Share
|
|
Jun 07
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+36.96%
|
$90,000
$4.12 P/Share
|
|
Jun 07
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.08%
|
$227,500
$35.0 P/Share
|
|
Jun 07
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.72%
|
$26,000
$4.12 P/Share
|
|
Apr 26
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.08%
|
$227,500
$35.0 P/Share
|
|
Apr 26
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.72%
|
$26,000
$4.12 P/Share
|
|
Apr 16
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
56,324
-42.17%
|
$1,802,368
$32.36 P/Share
|